Annetine Gelijns

Search results

• MESOBLAST LIMITED : - First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS

  Moskowitz, A., Bagiella, E. & Gelijns, A.

  7/05/20

  2 items of Media coverage

  Press/Media

• Mesoblast Limited: FIRST PATIENTS DOSED IN PHASE 2/3 RANDOMIZED CONTROLLED TRIAL OF MESOBLAST’S REMESTEMCEL-L FOR COVID-19 ACUTE RESPIRATORY DISTRESS SYNDROME

  Moskowitz, A., Bagiella, E. & Gelijns, A.

  7/05/20

  1 item of Media coverage

  Press/Media

• First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast’s Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome

  Moskowitz, A., Bagiella, E. & Gelijns, A.

  6/05/20

  1 item of Media coverage

  Press/Media

• MESOBLAST : First Patients Dosed in Phase 2/3 Trial for COVID-19 ARDS

  Moskowitz, A., Bagiella, E. & Gelijns, A.

  6/05/20

  1 item of Media coverage

  Press/Media

• First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast's Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome Australian Stock Exchange:MSB.AX

  Moskowitz, A., Bagiella, E. & Gelijns, A.

  6/05/20

  1 item of Media coverage

  Press/Media

• First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast's Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome

  Moskowitz, A., Bagiella, E. & Gelijns, A.

  6/05/20

  1 item of Media coverage

  Press/Media

• First Patients Dosed in Phase 2/3 Randomized Controlled Trial of Mesoblast’s Remestemcel-l for COVID-19 Acute Respiratory Distress Syndrome

  Moskowitz, A., Bagiella, E. & Gelijns, A.

  5/05/20 → 6/05/20

  22 items of Media coverage

  Press/Media

• Planned Clinical Trial of Allogeneic Stem Cell Therapy Remestemcel-L in Patients with COVID-19

  Osman, K., Levine, J. & Gelijns, A.

  20/04/20

  1 item of Media coverage

  Press/Media

• NY ‘virus capital’ as PM tells Aussies to stay home

  Gelijns, A.

  9/04/20 → 10/04/20

  3 items of Media coverage

  Press/Media

• Australia’s COVID-19 death toll hits 54

  Gelijns, A.

  10/04/20

  2 items of Media coverage

  Press/Media

• Mount Sinai Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients

  Moskowitz, A., Bagiella, E., Osman, K., Levine, J., Gelijns, A. & Iancu-Rubin, C.

  10/04/20

  2 items of Media coverage

  Press/Media

• Mount Sinai Health System Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients

  Moskowitz, A., Bagiella, E., Osman, K., Levine, J., Gelijns, A. & Iancu-Rubin, C.

  10/04/20

  1 item of Media coverage

  Press/Media

• Mount Sinai Leading the Way in Innovative Stem Cell Therapy for COVID-19 Patients

  Moskowitz, A., Levine, J., Bagiella, E., Osman, K., Gelijns, A. & Iancu-Rubin, C.

  10/04/20

  1 item of Media coverage

  Press/Media

• Australia ‘on the cusp’ of virus breakthrough

  Gelijns, A.

  10/04/20

  1 item of Media coverage

  Press/Media

• -Mesoblast limited - US NIH Trials Network to Conduct COVID-19 Phase 2/3 Trial

  Gelijns, A.

  10/04/20

  1 item of Media coverage

  Press/Media

• NY’s search for funeral directors as PM tells Aussies to stay home

  Gelijns, A.

  9/04/20

  2 items of Media coverage

  Press/Media

• PM urges Aussies to stay home in Easter message

  Gelijns, A.

  9/04/20

  2 items of Media coverage

  Press/Media

• Mesoblast Partners With The Cardiothoracic Surgical Trials Network Established By The U.S. National Institutes Of Health's National Heart, Lung And Blood Institute To Conduct Randomized Controlled Trial Of Remestemcel-L For Patients With Acute Respiratory

  Gelijns, A.

  8/04/20 → 9/04/20

  3 items of Media coverage

  Press/Media

• Australia’s curve ‘continues to flatten signi’

  Gelijns, A.

  9/04/20

  2 items of Media coverage

  Press/Media

• Qantas flights to rescue Aussies stranded overseas

  Gelijns, A.

  9/04/20

  1 item of Media coverage

  Press/Media

• MESOBLAST PARTNERS WITH THE CARDIOTHORACIC SURGICAL TRIALS NETWORK ESTABLISHED BY THE U.S. NATIONAL INSTITUTES OF HEALTH’S NATIONAL HEART, LUNG AND BLOOD INSTITUTE TO CONDUCT RANDOMIZED CONTROLLED TRIAL OF REMESTEMCEL-L FOR PATIENTS WITH ACUTE RESPIRATORY

  Gelijns, A.

  8/04/20 → 9/04/20

  12 items of Media coverage

  Press/Media

• Mesoblast secures US stem cell treatment trial for Covid-19

  Gelijns, A.

  8/04/20

  1 item of Media coverage

  Press/Media

• Clinical Trial: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  Gelijns, A.

  23/01/20

  1 item of Media coverage

  Press/Media

• Clinical Trial: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  Gelijns, A.

  20/01/20

  1 item of Media coverage

  Press/Media

• Clinical Trial: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG

  Gelijns, A.

  7/01/20

  1 item of Media coverage

  Press/Media